News | Radiology Business | February 28, 2022

Boston Imaging reflects the company’s commitment to delivering best-in-class Samsung imaging devices to customers nationwide

NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, announced today that the company’s Digital Radiography and Ultrasound (DR & US) business will operate under a new brand called Boston Imaging.

February 28, 2022 — NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, announced today that the company’s Digital Radiography and Ultrasound (DR & US) business will operate under a new brand called Boston Imaging.

“This is a momentous day for the company, as it will allow us even greater focus on our core expertise, providing the U.S. market with innovative, best-in-class Digital Radiography and Ultrasound imaging devices with Samsung healthcare technology at the core,” said David Legg, Vice President, Ultrasound and Digital Radiography, Boston Imaging. “As we continue gaining market leadership, this change will also allow Boston Imaging to have a more dedicated focus for growing the business.”

“The Samsung name is synonymous with industry-leading imaging technology,” said Legg. “In the healthcare imaging market, Samsung is the only true technology company that is now in healthcare imaging, while competitors come from industrial roots that have pursued healthcare as an add-on business. This company specializes in delivering exquisite imaging results.” Our new brand, Boston Imaging, reinforces the strength of our legacy and signals the potential of our future.

Our past advancements and achievements within the two modalities include the current introduction of innovative products such as the V8 Ultrasound system and artificial intelligence solutions, like Auto Lung Nodule Detection (ALND) tool, in Digital Radiography.

Boston Imaging’s team mission is improving patient care by developing outstanding, customer-centric imaging solutions quickly and with passion. We remain committed to our vision of making the world a healthier place by empowering clinicians to diagnose their patients more confidently, quickly and cost-effectively.

We will continue to maintain our normal business operations and operating structure. The legal entity and name of the company remains NeuroLogica Corp. We will be Doing Business As (DBA), Boston Imaging. The mobile computed tomography (CT) business will continue to operate under the existing company name, NeuroLogica.

For more information: www.bostonimaging.com


Related Content

News | Focused Ultrasound Therapy

May 7, 2026 — Openwater, an open-source medical technology company has announced a collaboration with the Sharma Lab, a ...

Time May 07, 2026
arrow
News | Radiation Oncology

April 27, 2026 — Radiation oncologists from across the country were in Washington in late April to warn lawmakers that ...

Time May 04, 2026
arrow
News

April 30, 2026 — The American College of Radiology has congratulated Nicole B. Saphier, MD, on her nomination to be ...

Time April 30, 2026
arrow
News | Artificial Intelligence

April 20, 2026 — DeepTek, provider of the Augmento platform and deepc, the company behind deepcOS, have introduced a ...

Time April 23, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Computed Tomography (CT)

April 2, 2026 — Nano-X Imaging Ltd. recently announced its U.S.-based subsidiary, Nanox Impact Inc., has signed a new ...

Time April 08, 2026
arrow
News | Teleradiology

April 1, 2026 — Premier Radiology Services has acquired Global Imaging Solutions (GLOBIS), a leading teleradiology group ...

Time April 03, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Radiology Business

March 1, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that practice turnover (i.e ...

Time March 19, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
Subscribe Now